semaglutide and kidney issues FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes chronic kidney disease compared to placebo. Investigators Semaglutide in Diabetic Kidney Disease:
Description
A rat study showed only an 11% increase in plasma antioxidant concentration compared to unfermented turmeric, and laboratory research found fermentation increased curcumin concentration by just 10% [1]
You can tell they prioritize both safety and client experience
If you're post-cholecystectomy and considering GLP-1 therapy, discussing your biomarker profile, genetic predispositions, and current GI symptoms with a qualified healthcare provider helps determine the safest and most effective approach
Discover a comprehensive list of at-home teeth-whitening kits here
